SK MEDITECH PRIVATE LIMITED has extended its reach globally by entering the markets of Asia, Europe, Africa and Latin America:

• Commonwealth of Independent States (CIS) - 1.Russia, 2.Ukraine, 3.Belarus, 4.Kazakhstan, 5.Uzbekistan
• Latin America – 1. Peru, 2. Chile, 3. Venezuela, 4.Guatemala, 5.Bolivia, 6.Trinidad & Tobago
• Africa – 1. Nigeria, 2.Ghana, 3.Kenya
• Asian Countries – 1.Thailand, 2.Myanmar, 3.Vietnam, 4.Malaysia, 5.Philippines, 6.Cambodia, 7.Srilanka

Today, SK Meitech Private Limited is making its presence felt in the world market now, through leveraging its manufacturing capacity, quality of products and international alliances. International business contribute about 20% of the company’s revenue and it is set to grow to more than 40% in the coming 2 years. The company is in the making of a strong base to broaden its horizons by producing various dosage forms encompassing a vast range of therapeutic categories.